Vascular Na+/Ca2+ exchanger: Implications for the pathogenesis and therapy of salt-dependent hypertension

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 290, Issue 3, 2006, Pages

  Iwamoto, Takahiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Hypertension; Na+ K+ ATPase; Salt intake; Vascular smooth muscle

Indexed keywords

2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; 2 [4 (2,5 DIFLUOROBENZYLOXY)PHENOXY] 5 ETHOXYANILINE; HUMORAL ANTIBODY; OUABAIN; PROTEIN INHIBITOR; SN 6; SODIUM CALCIUM EXCHANGE PROTEIN; UNCLASSIFIED DRUG; YM 244769; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTIHYPERTENSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD VESSEL TONE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG INHIBITION; DRUG STRUCTURE; EXPERIMENTAL MODEL; GENETIC ENGINEERING; HYPERTENSION; MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SALT INTAKE; VASCULAR SMOOTH MUSCLE; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION; MUSCLE, SMOOTH, VASCULAR; NA(+)-K(+)-EXCHANGING ATPASE; SODIUM CHLORIDE, DIETARY;

EID: 33645405103     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00592.2005     Document Type: Review

References (100)

1. +. Am J Physiol Heart Circ Physiol 279: H679-H691, 2000.
2. +-ATPase inhibitor in patients after acute myocardial infarction. Hypertension 31: 1097-1103, 1998.
3. Blaustein MP and Hamlyn JM. Pathogenesis of essential hypertension. A link between dietary salt and high blood pressure. Hypertension 18: III184-III195, 1991.
4. Blaustein MP and Lederer WJ. Sodium/calcium exchange: its physiological implications. Physiol Rev 79: 763-854, 1999.
5. 2+ exchangers with altered ionic regulation. Mol Pharmacol 65: 802-810, 2004.
6. 2+ transients and contraction in vascular smooth muscle. Am J Physiol Heart Circ Physiol 259: H409-H423, 1990.
7. Brading AF and Lategan TW. Na-Ca exchange in vascular smooth muscle. J Hypertens 3: 109-116, 1985.
8. Chernysh O, Condrescu M, and Reeves JP. Calcium-dependent regulation of calcium efflux by the cardiac sodium/calcium exchanger. Am J Physiol Cell Physiol 287: C797-C806, 2004.
9. Conway J and Lauwers P. Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide. Circulation 21: 21-27, 1960.
10. Curtis JJ, Luke RG, Dustan HP, Kashgarian M, Whelchel JD, Jones P, and Diethelm AG. Remission of essential hypertension after renal transplantation. N Engl J Med 309: 1009-1015, 1983.
11. Dahl LK, Heine M, and Thompson K. Genetic influence of the kidneys on blood pressure. Evidence from chronic renal homografts in rats with opposite predispositions to hypertension. Circ Res 40: 94-101, 1974.
12. 2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro. Am J Physiol Heart Circ Physiol 288: H477-H485, 2005.
13. Droogmans G and Casteels R. Sodium and calcium interactions in vascular smooth muscle cells of the rabbit ear artery. J Gen Physiol 74: 57-70, 1979.
14. 2+ exchange by KB-R7943: transport mode selectivity and antiarrhythmic consequences. Am J Physiol Heart Circ Physiol 281: H1334-H1345, 2001.
15. Elliott P, Stamler J, Nichols R, Dyer AR, Stamler R, Kesteloot H, and Marmot M. Intersalt revisited: further analyses of 24-hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. Br Med J 312: 1249-1253, 1996.
16. Fedorova OV, Lakatta EG, and Bagrov AY. Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of Dahl rats. Circulation 102: 3009-3014, 2000.
17. Ferrari P, Ferrandi M, Tripodi G, Torielli L, Padoani G, Minotti E, Melloni P, and Bianchi G. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension. J Pharmacol Exp Ther 288: 1074-1083, 1999.
18. Ferrari P, Torielli L, Ferrandi M, Padoani G, Duzzi L, Florio M, Conti F, Melloni P, Vesci L, Corsico N, and Bianchi G. PST2238: a new antihypertensive compound that antagonizes the long-term pressor effect of ouabain. J Pharmacol Exp Ther 285: 83-94, 1998.
19. i in a restricted space of guinea-pig ventricular cells. J Physiol 509: 457-470, 1998.
20. Goto A and Yamada K. Putative roles of ouabainlike compound in hypertension: revisited. Hypertens Res 23: S7-S13, 2000.
21. Guyton AC. Blood pressure control: special role of the kidneys and body fluid. Science 252: 1813-1816, 1991.
22. Haddy FJ. Ionic control of vascular smooth muscle cells. Kidney Int 346: S2-S8, 1988.
23. Haddy FJ and Pamnani MB. Role of dietary salt in hypertension. J Am Coll Nutr 14: 428-438, 1995.
24. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, Mathews WR, and Ludens JH. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci USA 88: 6259-6263, 1991.
25. Hamlyn JM, Hamilton BP, and Manunta P. Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis. J Hypertens 14: 151-167, 1996.
26. +)-ATPase associated with essential hypertension. Nature 300: 650-652, 1982.
27. +-ATPase with high sodium intake in patients with essential hypertension. J Clin Hypertens 3: 419-429, 1987.
28. 2 with the XIP region of the cardiac Na/Ca exchanger. Am J Physiol Cell Physiol 278: C661-C666, 2000.
29. 2. Science 273: 956-959, 1996.
30. 2+ level in guinea-pig aorta. Eur J Pharmacol 224: 71-76, 1992.
31. 2+ exchange by SN-6 [2-[4-(4-nitrobenzyloxy)benzyl]thiazolidine-4- carboxylic acid ethyl ester], a novel benzyloxyphenyl derivative. Mol Pharmacol 66: 45-55, 2004.
32. 2+ exchange (NCX1) inhibition by SEA0400. J Biol Chem 279: 7544-7553, 2004.
33. 2+ exchanger. Mol Pharmacol 59: 524-531, 2001.
34. 2+ exchanger type-1 in vascular smooth muscle. Nat Med 10: 1193-1199, 2004.
35. 2+ exchanger. FEBS Lett 446: 264-268, 1999.
36. 2+ exchanger via protein kinase C. J Biol Chem 271: 13609-13615, 1996.
37. 2+ exchanger isoforms by divalent cations and isothiourea derivative. Am J Physiol Cell Physiol 275: C423-C430, 1998.
38. 2+ affinity. J Biol Chem 275: 38571-38580, 2000.
39. 2+ exchanger. J Biol Chem 270: 8996-9001, 1995.
40. 2+ exchange in cells expressing NCX1. J Biol Chem 271: 22391-22397, 1996.
41. Johnson RJ, Rodriguez-Iturbe B, Nakagawa T, Kang DH, Feig DI, and Herrera-Acosta J. Subtle renal injury is likely a common mechanism for salt-sensitive essential hypertension. Hypertension 45: 326-330, 2005.
42. 2+ exchanger in arteries: identification by immunoblotting and immunofluorescence microscopy. Am J Physiol Cell Physiol 266: C234-C242, 1994.
43. + pump alpha subunit isoforms in plasmalemma. Physiological implications. Ann NY Acad Sci 834: 524-536, 1997.
44. Kaczorowsky GJ, Garcia ML, King VF, and Slaughter RS. Development and use of inhibitors to study sodium-calcium exchange. In: Sodium-Calcium Exchange, edited by Allen TJ, Noble D, and Reuter H. Oxford, UK: Oxford Science Publications, 1989, p. 66-101.
45. Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K, Harada K, Miyamoto S, Nakazawa H, Won KJ, and Sato K. Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev 49: 157-230, 1997.
46. 2+ influx in rabbit abdominal aorta: role of Na-Ca exchange. Am J Physiol Cell Physiol 265: C1325-C1331, 1993.
47. 2+ exchange current by KB-R7943 in guinea-pig cardiac myocytes. Br J Pharmacol 128: 969-974, 1999.
48. Krushkal J, Ferrell R, Mockrin SC, Turner ST, Sing CF, and Boerwinkle E. Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation 99: 1407-1410, 1999.
49. Kuramochi T, Kakefuda A, Yamada H, Ogiyama T, Taguchi T, and Sakamoto S. Synthesis and structure-activity relationships of benzyloxyphenyl derivatives as a novel class of NCX inhibitors: effects on heart failure. Bioorg Med Chem 13: 725-734, 2005.
50. 2+ exchanger, NCX1. J Pharmacol Exp Ther 311: 748-757, 2004.
51. 2+ exchanger. J Biol Chem 266: 1014-1020, 1991.
52. Lifton RP, Gharavi AG, and Geller DS. Molecular mechanisms of human hypertension. Cell 104: 545-556, 2001.
53. 2+ exchanger inhibitors SEA0400 and KB-R7943. Am J Physiol Heart Circ Physiol 284: H903-H910, 2003.
54. Manning RD Jr, Coleman TG, Guyton AC, Norman RA Jr, and McCaa RE. Essential role of mean circulatory filling pressure in salt-induced hypertension. Am J Physiol Regul Integr Comp Physiol 236: R40-R47, 1979.
55. Manunta P, Rogowski AC, Hamilton BP, and Hamlyn JM. Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J Hypertens 12: 549-560, 1994.
56. Manunta P, Stella P, Rivera R, Ciurlino D, Cusi D, Ferrandi M, Hamlyn JM, and Bianchi G. Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension 34: 450-456, 1999.
57. Matlib MA, Whitmer KR, MacCarthy EP, and Ooi BS. Sodium-calcium exchange exists across the cell membrane of intact vascular smooth muscle cells. J Hypertens 4: S222-S223, 1986.
58. 2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. J Pharmacol Exp Ther 298: 249-256, 2001.
59. 2+ exchanger by the endogenous XIP region. J Gen Physiol 109: 273-286, 1997.
60. 2+-binding domain. J Gen Physiol 105: 403-420, 1995.
61. Meneton P, Jeunemaitre X, De Wardener HE, and MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 85: 679-715, 2005.
62. + pump and sarcoplasmic reticulum in smooth muscle. Nature 365: 657-660, 1993.
63. Morgan DA, DiBona GF, and Mark AL. Effects of interstrain renal transplantation on NaCl-induced hypertension in Dahl rats. Hypertension 15: 436-442, 1990.
64. Mulvany MJ, Aalkjaer C, and Petersen TT. Intracellular sodium, membrane potential, and contractility of rat mesenteric small arteries. Circ Res 54: 740-749, 1984.
65. 2+ exchanger and tissue-specific expression of isoforms. J Biochem (Tokyo) 114: 528-534, 1993.
66. 2+ exchanger. J Biol Chem 271: 13385-13391, 1991.
67. 2+ exchanger. J Biol Chem 274: 910-917, 1999.
68. 2+ exchanger. J Biol Chem 280: 1061-1069, 2005.
69. Ozaki H and Urakawa N. Na-Ca exchange and tension development in guinea-pig aorta. Naunyn Schmiedebergs Arch Pharmacol 309: 171-178, 1979.
70. 2+ exchanger NCX1. Am J Physiol Cell Physiol 279: C393-C402, 2000.
71. Petersen TT and Mulvaney MJ. Effect of sodium gradient on the rate of relaxation of rat mesenteric small arteries from potassium contractures. Blood Vessels 21: 279-289, 1984.
72. 2+ exchange inhibitor KB-R7943 also blocks native and expressed neuronal nicotinic receptors. Br J Pharmacol 130: 1893-1902, 2000.
73. Pinto YM, Paul M, and Ganten D. Lessons from rat models of hypertension: from Goldblatt to genetic engineering. Cardiovasc Res 39: 77-88, 1998.
74. 2+ signaling in smooth muscle: why two membranes are better than one. Trends Pharmacol Sci 25: 8-15, 2004.
75. 2+ exchanger. J Biol Chem 276: 194-199, 2001.
76. 2+ exchanger isoforms NCX1, NCX2, and NCX3 in rat. Am J Physiol Cell Physiol 272: C1250-C1261, 1997.
77. Quednau BD, Nicoll DA, and Philipson KD. The sodium/calcium exchanger family-SLC8. Pflügers Arch 447: 543-548, 2004.
78. Reeves JP. Sodium-calcium exchange: a possible target for drug development. Drug Dev Res 18: 295-304, 1989.
79. Reuter H, Blaustein MP, and Haeusler G. Na-Ca exchange and tension development in arterial smooth muscle. Philos Trans R Soc Lond B Biol Sci 265: 87-94, 1973.
80. 2+ exchange inhibitors. Circ Res 91: 90-92, 2002.
81. 2+ exchanger is essential for the action of cardiac glycosides. Circ Res 90: 305-308, 2002.
82. 2+ overload in rat ventricular myocytes. Circulation 101: 1441-1446, 2000.
83. Schneider R, Wray V, Nimtz M, Lehmann WD, Kirch U, Antolovic R, and Schoner W. Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump. J Biol Chem 273: 784-792, 1998.
84. Schoner W. Endogenous cardiac glycosides, a new class of steroid hormones. Eur J Biochem 269: 2440-2448, 2002.
85. Schulze DH, Muqhal M, Lederer WJ, and Ruknudin AM. Sodium/calcium exchanger (NCX1) macromolecular complex. J Biol Chem 278: 28849-28855, 2003.
86. 2+ exchange: molecular and pharmacological aspects. Circ Res 88: 864-876, 2001.
87. 2+ exchanger knockdown by antisense oligodeoxynucleotides in arterial myocytes. Am J Physiol Cell Physiol 275: C251-C259, 1998.
88. 2+ exchange in primary cultured arterial myocytes. Am J Physiol Cell Physiol 269: C1340-C1345, 1995.
89. 2+ produced by angiotensin II in cultured arterial muscle cells. J Biol Chem 262: 17455-17460, 1987.
90. 2+ exchange inhibitor KB-R7943. Neuropharmacology 38: 1235-1242, 1999.
91. Takahashi H. Endogenous digitalislike factor: an update. Hypertens Res 23: S1-S5, 2000.
92. 2+ exchanger, on myocardial ischemia-reperfusion injuries. Eur J Pharmacol 458: 155-162, 2003.
93. Tanaka H, Nishimaru K, Aikawa T, Hirayama W, Tanaka Y, and Shigenobu K. Effect of SEA0400, a novel inhibitor of sodium-calcium exchanger, on myocardial ionic currents. Br J Pharmacol 135: 1096-1100, 2002.
94. Tobian L. Salt and hypertension. Hypertension 17 Suppl: 51-58, 1992.
95. Van Brummelen P, Man in't Veld AJ, and Schalekamp MA. Hemodynamic changes during long-term thiazide treatment of essential hypertension in responders and nonresponders. Clin Pharmacol Ther 27: 328-336, 1980.
96. 2+ exchanger gene leads to cardiomyocyte apoptosis and defects in heartbeat. J Biol Chem 275: 36991-36998, 2000.
97. 2+ exchange current in guinea-pig cardiac ventricular cells. Br J Pharmacol 119: 555-563, 1996.
98. Weber CR, Ginsburg KS, Philipson KD, Shannon TR, and Bers DM. Allosteric regulation of Na/Ca exchange current by cytosolic Ca in intact cardiac myocytes. J Gen Physiol 117: 119-131, 2001.
99. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 27: 481-490, 1996.
100. Yamori Y, Nara Y, Mizushima S, Mano M, Sawamura M, Kihara M, and Horie R. International cooperative study on the relationship between dietary factors and blood pressure: a report from the Cardiovascular Diseases and Alimentary Comparison (CARDIAC) Study. J Cardiovasc Pharmacol 16: S43-S47, 1990.